Characterization of the porcine synovial fluid proteome and a comparison to the plasma proteome  by Bennike, Tue Bjerg et al.
Contents lists available at ScienceDirect
Data in Brief
Data in Brief 5 (2015) 241–247http://d
2352-34
(http://c
n Corr
E-mjournal homepage: www.elsevier.com/locate/dibData ArticleCharacterization of the porcine synovial
ﬂuid proteome and a comparison to the
plasma proteomeTue Bjerg Bennike a,b,n, Omar Barnaby b, Hanno Steen b, Allan Stensballe a
a Department of Health Science and Technology, Aalborg University, Fredrik Bajersvej 3B, 9220 Aalborg, Denmark
b Departments of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USAa r t i c l e i n f o
Article history:
Received 18 June 2015
Received in revised form
23 August 2015
Accepted 24 August 2015
Available online 4 September 2015
Keywords:
Synovial ﬂuid
Plasma
Proteomics
Post-translational modiﬁcation
Human
Porcine
Pig
Optimization
Digestionx.doi.org/10.1016/j.dib.2015.08.028
09/& 2015 The Authors. Published by Else
reativecommons.org/licenses/by/4.0/).
esponding author. Tel.: þ45 2613 9003; fa
ail address: tbe@hst.aau.dk (T.B. Bennike).a b s t r a c t
Synovial ﬂuid is present in all joint cavities, and protects the
articular cartilage surfaces in large by lubricating the joint, thus
reducing friction. Several studies have described changes in the
protein composition of synovial ﬂuid in patients with joint disease.
However, the protein concentration, content, and synovial ﬂuid
volume change dramatically during active joint diseases and
inﬂammation, and the proteome composition of healthy synovial
ﬂuid is incompletely characterized.
We performed a normative proteomics analysis of porcine
synovial ﬂuid, and report data from optimizing proteomic methods
to investigate the proteome of healthy porcine synovial ﬂuid
(Bennike et al., 2014 [1]). We included an evaluation of different
proteolytic sample preparation techniques, and an analysis of
posttranslational modiﬁcations with a focus on glycosylation. We
used pig (Sus Scrofa) as a model organism, as the porcine immune
system is highly similar to human and the pig genome is
sequenced. Furthermore, porcine model systems are commonly
used large animal models to study several human diseases.
In addition, we analyzed the proteome of human plasma, and
compared the proteomes to the obtained porcine synovial ﬂuid
proteome. The proteome of the two body ﬂuids were found highly
similar, underlining the detected plasma derived nature of many
synovial ﬂuid components. The healthy porcine synovial ﬂuid
proteomics data, human rheumatoid arthritis synovial ﬂuid pro-
teomics data used in the method optimization, human plasma
proteomics data, and search results, have been deposited to thevier Inc. This is an open access article under the CC BY license
x: þ45 9815 4008.
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T.B. Bennike et al. / Data in Brief 5 (2015) 241–247242ProteomeXchange Consortium via the PRIDE partner repository
with the dataset identiﬁer PXD000935.
& 2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations tableSubject area Biology
ore speciﬁc sub-
ject areaAn analysis of the protein component of porcine synovial ﬂuid, and a comparison
to human plasma.ype of data Raw ﬁles and text/excel ﬁles
ow data was
acquiredMass spectrometry liquid chromatography
Two different high-resolution/high-accuracy mass spectrometer
systems were used: TripleTOF 5600 (SCIEX) and Q Exactive
(Thermo Scientiﬁc)ata format Raw and analyzed data.
xperimental
factorsHuman and porcine synovial ﬂuid as well as human plasma was analyzed.xperimental
featuresSynovial ﬂuid was digested using trypsin with in solution digestion, ﬁlter aided
sample preparation, and in-gel digestion protocols. Plasma was digested using
ﬁlter aided sample preparation. The puriﬁed peptides were analyzed by elec-
trospray ionization liquid chromatography mass spectrometry.ata source
locationSteen & Steen Laboratory, Enders Research Building, Boston Children’s Hospital,
320 Longwood Ave, Boston, MA, USA.ata accessibility The MS proteomics data have been deposited to the ProteomeXchange
Consortium via the PRIDE partner repository with the dataset identiﬁer
PXD000935 [2–5]. Direct download link: http://www.ebi.ac.uk/pride/
archive/projects/PXD000935Value of the data
 Increase our knowledge of synovial ﬂuid in healthy state, usable for future studies on joints and
joint disease.
 Investigate the plasma-derived nature of many synovial ﬂuid proteins.
 Identify differences and similarities between the porcine proteome and the human proteome,
usable in assessing pigs as a model system for human diseases.
 Information regarding the proteome of synovial ﬂuid from a healthy joint will form the basis for
research in joint diseases, such as osteoarthritis and rheumatoid arthritis.1. Experimental design
Synovial ﬂuid is an ultraﬁltrate of plasma, and the two body ﬂuids share many similarities in terms of
protein composition [6,7]. To investigate the protein component of healthy synovial ﬂuid, we analyzed the
proteome of synovial ﬂuid from healthy porcine knee joints. We used pig as a model organism, as the pig
proteome is similar to humans [1]. The protein concentration in synovial ﬂuid from healthy knee joints is
approximately 25 mg/mL, and albumin constitutes approximately 12 mg/mL [8–12]. Because high-abun-
dant proteins might hinder the identiﬁcation of lesser abundant ones, most work conducted on synovial
ﬂuid has employed immunodepletion strategies and/or gel-based separation techniques [1]. However, in-
gel digestion strategies are, while robust, typically not compatible with high-throughput proteome analyses
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quantitation proteomics methods, utilizing digestion method optimization and two state-of-the-art mass
spectrometers, to increase the number of identiﬁed synovial ﬂuid proteins.2. Materials and methods
2.1. Collection of synovial ﬂuid samples
We utilized six adolescent Yucatan minipigs (Coyote CCI, Douglas, MA, USA), aged 12–15 months
for the study. The minipigs were housed and monitored by the Animal Resources at Boston Children's
Hospital and handled according to the Institutional Animal Care and Use Committee protocols.
Following acclimation to the environment for at least three days, synovial ﬂuid was extracted
using a needle. When necessary to facilitate the extraction, 3 mL sterile saline was injected into the
joint, which was bend ten times. Additionally, synovial ﬂuid was obtained from a rheumatoid arthritis
patient according to an approved IRB protocol (IRB-P00006443). To remove cells and cell debris, the
samples were centrifuged at 3.000g at room temperature for 10 min, and the supernatants were
stored at 80 °C. The protein concentration was estimated for normalization of sample material
using a bicinchoninic acid assay kit (Bio-Rad, Hercules, CA, USA) according to manufacturer's
instructions.
2.2. Synovial ﬂuid protein digestion
To increase the number of identiﬁed proteins we evaluated and combined data from three trypsin
digest protocols.
1. Filter-Aided Sample Preparation (FASP) Digestion: 90 mg total synovial ﬂuid protein was digested
using a FASP digestion kit (Protein Discovery, San Diego, CA, USA) according to manufacturer's
instructions with 30 kDa molecular weight cutoff spin ﬁlters. To assess the need of glycan removal
when working with synovial ﬂuid peptide-N4-(N-acetyl-beta-glucosaminyl)-asparagine amidase
(PNGase F) (New England BioLabs, Ipswich, MA, USA) was added to these samples prior to the
trypsin digestion step according to manufacturer's instructions, and the samples were incubated
overnight at 37 °C, after which trypsin was added and the FASP protocol was resumed.
2. In-gel digestion: three samples of 150 mg total synovial ﬂuid protein was prepared for SDS-PAGE
with Laemmli Sample Buffer (Bio-Rad, Hercules, USA) according to manufacturer’s instructions. The
sample was fractionated using NuPAGE 4–12% Bis-Tris mini gels (Invitrogen) at 150 V for 65 min in
MOPS SDS-running buffer (Invitrogen). The gel was stained using Coomassie blue SimplyBlue
SafeStain (Invitrogen) according to manufacturer’s instructions. Three gel-lanes were loaded with
150 mg total synovial ﬂuid protein, each divided into 10 sections, and subjected to standard in-gel
tryptic digestion as previously described [16–18].
3. In-solution digestion: performed according to Gallien et al. [19]. 90 mg total synovial ﬂuid protein
was diluted with 8 M urea 100 mM ammonium bicarbonate to a ﬁnal volume of 25 mL. The sample
was reduced with dithiothreitol at a ﬁnal concentration of 12 mM for 30 min at 37 °C, and alkylated
with iodoacetamide at a ﬁnal concentration of 40 mM for 1 h at room temperature in the dark. The
samples were diluted with 0.1 M ammonium bicarbonate to a total volume of 100 mL, 2 mg trypsin
was added and the sample was digested overnight at 37 °C.
For all digestion methods, a 50:1 (w/w) ratio protein to sequencing grade modiﬁed trypsin
(Promega, Fitchburg, MA, USA) was added, and the samples were digested overnight at 37 °C. After
trypsin digestion, the samples were desalted with TARGA C18 columns (Nest Group, Southborough,
MA, USA), dried in a vacuum centrifuge, and the dry product was stored at 80 °C. Prior to liquid
chromatography tandem mass spectrometry (LC-MS/MS) analysis, the peptides were resuspended in
5% acetonitrile (ACN), 5% formic acid (FA).
T.B. Bennike et al. / Data in Brief 5 (2015) 241–2472442.3. Human plasma sample preparation
Human plasma was acquired for an ongoing method optimization study using an anonymized,
discarded plasma sample, and is therefore not considered research of human subjects. Hundred mg
plasma protein was digested using the FASP protocol, modiﬁed to use 10 kDa molecular weight cutoff
spin ﬁlters. The proteins were digested overnight at 37 °C, using a 25:1 (w/w) ratio of proteins to
trypsin/LysC mix (Promega, Madison, WI, USA). The peptides were desalted with Oasis HLB columns
(Waters, Milford, MA, USA), fractionated into 12-fractions by isoelectric focusing on a 3100 OFFGEL
fractionator (Agilent, Santa Clara, CA, USA). The resulting fractions were desalted using Oasis HLB
columns (Waters, Milford, MA, USA) and stored at 80 °C. Prior to LC-MS/MS analysis, the peptides
were resuspended in 2% ACN, 0.1% FA.
2.4. LC-MS/MS analysis
To increase the number of identiﬁed synovial ﬂuid proteins, two different high resolution/high
accuracy mass spectrometer systems were used for the discovery-based proteomic experiment:
1. A TripleTOF 5600 (SCIEX, Framingham, MA, USA) connected online with a nanoﬂow UPLC and a
NanoFlex system (Eksigent/SCIEX). The samples were loaded onto a 15 cm reversed phase C18
200 mm chip with 2 mL/min in 100% solvent A (0.1% FA). The samples were then separated using a
15 cm reversed phase C18 75 mm chip, and eluted with a linear gradient of 2% solvent B (0.1% FA in
ACN) which was raised to 35% solvent B over 120 min (60 min for in-gel digested samples) at a
constant ﬂow rate of 500 nL/min.
2. A Q Exactive (Thermo Scientiﬁc, Waltham, USA) connected online to an EASY-nUHPLC 1000
(Thermo Scientiﬁc). The samples were loaded onto a 10.5 cm reversed phase C18 PicoChip column
(Picochip, Bath, England) with a ﬂow rate of approximately 1 mL/min in 98% solvent A and 2%
solvent B, and eluted with eluent B using a linear gradient which was raised to 35% over 120 min at
a constant ﬂow rate of 300 nL/min.
2.5. Proteomic data analysis
The SCIEX.wiff data-ﬁles were analyzed using ProteinPilot 4.5 (Rev. 1656, Paragon Algorithm 4.5.0.0). To
identify the most commonly single observed PTMs, data-ﬁles were searched in thorough-mode with a
focus on biological modiﬁcations in ProteinPilot to include 303 different PTMs, and the result was assessed
using ProteinPilot Descriptive Statistics Template v3.001.
The.raw data-ﬁles from synovial ﬂuid analyzed on the Q Exactive were searched using MaxQuant
1.4.1.2. [20]. All standard settings were employed with carbamidomethyl(C) as a static modiﬁcation
and deamidation (NQR), oxidation (M), and protein N-terminal acetylation were included as variable
modiﬁcations. Label-free quantitation of all proteins was performed in MaxQuant based on integrated
precursor intensities. The human plasma samples was searched using Mascot v2.3.02 with identical
modiﬁcation settings to MaxQuant, parent tolerance of 10 ppm, and fragment tolerance of 0.03 Da.
Porcine synovial ﬂuid data was searched against the Uniprot Sus scrofa reference proteome database
(downloaded 11/09/2013, containing 26,070 entries). The rheumatoid arthritis patient synovial ﬂuid data
was searched against all reviewed Homo sapiens Uniprot proteins (downloaded 08/10/2013, containing
20,277 entries). The human plasma sample was searched against the Uniprot human database
(R2001_05_crp_T, containing 35,806 entries). All proteins and peptides are reported below a 1% false
discovery rate (FDR) cutoff.3. Data
The proteomics data and result-ﬁles from the analysis have been deposited to the ProteomeXchange
Consortium via the PRIDE partner repository with the dataset identiﬁer PXD000935 [2–5], and can be
downloaded directly (http://www.ebi.ac.uk/pride/archive/projects/PXD000935). Table 1 shows the list of
Table 2
Description of search ﬁle-names in the ProteomeXchange repository PXD000935.
Search ﬁles ﬁlename Description of content
[Filename]_PeptideSummary.txt ProteinPilot exported list of peptides.
[Filename] _ProteinSummary.txt ProteinPilot exported list of proteins.
[Filename] __FDR.xlsx ProteinPilot FDR analysis.
Transcriptome MQ Combined PorcineSF.zip MaxQuant result folder “combined” of Q Exactive porcine synovial ﬂuid
samples, search against a transcriptome database of the synovial
membrane,
and thus contains a list of synovial ﬂuid proteins expressed
by the synovium [1].
UniProt MQ Combined Plasma Human.zip MaxQuant result folder “combined” of human plasma, searched
against the human Uniprot database, and thus contains a list of
all identiﬁed human plasma proteins.
UniProt MQ Combined SF PorcineSF.zip MaxQuant result folder “combined” of Q Exactive porcine synovial
ﬂuid samples, search against the porcine Uniprot database,
and thus contains a list of all identiﬁed synovial ﬂuid proteins.
Table 1
Description of ﬁle-names in the ProteomeXchange repository PXD000935. 5600 (.wiff) MS ﬁles were searched using Pro-
teinPilot, and Q Exactive (.raw) MS ﬁles using MaxQuant. The number of identiﬁed proteins is reported.
File Sample type Species Digestion MS system # ID proteins
121029_TB_FD1 SF Porcine FASP 5600 191
121029_TB_FD7 SF Porcine FASP 5600 182
121029_TB_FD9 SF Porcine FASP 5600 164
121029_TB_UD1 SF Porcine In-solution 5600 103
121029_TB_UD7 SF Porcine In-solution 5600 104
121029_TB_UD9 SF Porcine In-solution 5600 101
121115_TB_D1_ingel# (fraction 1–10) SF Porcine In-gel 5600 192
121115_TB_D7_ingel# (fraction 1–10) SF Porcine In-gel 5600 173
121115_TB_D9_ingel# (fraction 1–10) SF Porcine In-gel 5600 161
121113_TB_HumanSF1_6 SF Human FASP 5600 183
121113_TB_HumanSF1_7 SF Human FASP 5600 183
121113_TB_HumanSF2_8 SF Human FASP 5600 172
121113_TB_HumanSF2_9 SF Human FASP 5600 154
130103_TB_SFGlycotest_SFDeglyco_1 SF Porcine PNGase F, FASP 5600 189
130103_TB_SFGlycotest_SFDeglyco_2 SF Porcine PNGase F, FASP 5600 184
130103_TB_SFGlycotest_SFUntreated_1 SF Porcine FASP 5600 184
130103_TB_SFGlycotest_SFUntreated_2 SF Porcine FASP 5600 189
NeatPlasma_2hr Plasma Human FASP Q Exactive 200
Tue_SF_FASP_143 (three replicates) SF Porcine FASP Q Exactive 242
Tue_SF_FASP_155 (three replicates) SF Porcine FASP Q Exactive 204
Tue_SF_FASP_165 (three replicates) SF Porcine FASP Q Exactive 231
Tue_SF_FASP_168 (three replicates) SF Porcine FASP Q Exactive 250
Tue_SF_FASP_37 (three replicates) SF Porcine FASP Q Exactive 164
Tue_SF_FASP_52 (three replicates) SF Porcine FASP Q Exactive 227
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and MS system. Table 2 shows the list of submitted analysis result ﬁles and a short description of the
content. In our data, the FASP protocol was the most efﬁcient, yielding the highest number of identiﬁable
proteins in synovial ﬂuid. Therefore, we conducted a comprehensive analysis of synovial ﬂuid from six
different pigs, analyzed in triplicates on a Q Exactive system. In addition, we conducted an analysis of
human plasma, and the data demonstrates the high degree of similarity between plasma and synovial ﬂuid,
and the plasma-derived nature of many synovial ﬂuid components. Many of these components were
further identiﬁed in the full research paper [1].
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